You are currently viewing Tapering Off Mirtazapine: A Slow, Patient-Directed Approach

Why would anyone want to taper off of mirtazapine?

Mirtazapine, sold under the brand name Remeron, is an antidepressant with a tetracyclic chemical structure. In the United States, its label lists one approved use, the treatment of major depressive disorder in adults.

Yet, ask a room full of patients why they were started on it, and many will not say depression. They will say sleep. Mirtazapine is a potent blocker of histamine receptors, and its label says that this action may explain how prominently drowsy the drug makes people.

So, the reasons for wanting off of it are practical. The depression has been in remission for a year or two, the morning grogginess never lifted, or the scale has moved in a direction nobody discussed at the first appointment, and increased appetite and weight gain are right there on the label. Or, you have simply decided that you no longer want to take it, and that reason is enough.

Dr. Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, helps patients taper off of psychiatric medications such as mirtazapine, and nearly every first visit starts with the same question. How do you come off of this drug without paying for the exit?

What happens if you stop mirtazapine cold turkey?

The label answers this one directly. It reports adverse reactions upon discontinuation, particularly when abrupt, and it recommends a gradual reduction in the dosage rather than an abrupt cessation. Its list includes dizziness, abnormal dreams, sensory disturbances such as electric shock sensations, agitation, anxiety, fatigue, confusion, headache, tremor, nausea, vomiting, and sweating, and it adds that other symptoms of clinical significance may occur.

Mirtazapine has an elimination half-life of roughly 20 to 40 hours, longer in women than in men. The drug does not vanish overnight, but it fades within days, and patients often describe the trouble arriving on the second or third day after a sudden stop. If symptoms become severe or frightening, call 911 or go to the nearest emergency room, and if thoughts of harming yourself appear at any point, call or text 988, the Suicide and Crisis Lifeline.

Unfortunately, the taper plan a patient receives is often two words at the end of a fifteen-minute visit. Just stop. Or, take it every other day, which is not a taper at all but a series of small cold turkeys. The label says otherwise, and so does the nervous system of anyone who has tried it.

Is mirtazapine addictive? Dependence is not addiction.

Mirtazapine is not an addictive drug. Nobody takes it to get high, nobody takes more of it to chase a feeling, and it is not a controlled substance. What mirtazapine does cause, with steady daily use, is physical dependence.

Physical dependence means that your brain has adjusted to the presence of the drug and now expects it. Take the drug away faster than the brain can readjust, and the brain complains. That is a medical condition created by a prescription, and it is treated by tapering, not by a meeting or a lecture about willpower.

Dependence is not addiction. In fact, the person who feels terrible three days after stopping mirtazapine is usually the person who took it exactly as prescribed, every night, for years. The prescription worked as designed. The exit plan was never written.

Why does the last part of the taper feel harder than the first?

Imagine making a pot of soup. The first spoonful of salt changes everything, the second helps a little, and by the fourth you cannot tell the difference. Now, run it in reverse. Taking away the fourth spoonful changes nothing, taking away the first changes the whole pot, and if you want the last of the salt out without anyone noticing, you take it out in pinches.

While a brain is not a pot of soup, the receptors that mirtazapine acts on behave much the same way. At a full dose the receptors are mostly occupied, and cutting the dose in half removes surprisingly little of the drug’s effect. Near the bottom, a small cut in milligrams removes a large share of what is left, and that is where the symptoms show up.

The Maudsley Deprescribing Guidelines build a mirtazapine taper around this curve, with each reduction a proportion of the current dose rather than a fixed number of milligrams, so the cuts shrink as the dose falls. By the end, the dose before stopping is far smaller than any tablet a pharmacy sells. This is the principle behind hyperbolic tapering, and it explains why a patient who breezed through the first few cuts hits a wall near the end. Take the salt out in pinches.

What does a careful mirtazapine taper actually look like?

It looks like a series of proportional reductions, each followed by a pause. The pause is where the taper is won or lost. After a cut, the brain needs time to catch up, and the pause gives it that time before the next cut is considered.

Symptoms after a reduction are information, not failure. If a cut brings insomnia, nausea, or dizziness that does not settle, the answer is to hold at the current dose until it does, and sometimes to step back to the previous dose and hold there. Fortunately, the nervous system usually settles, and the taper continues from stable footing. If you have already stopped and feel awful, it is not a bad idea to ask your prescriber about returning to the last dose that felt steady and tapering from there.

While the shape is the same for everyone, the pace is not, and the pace belongs to the patient. If the taper is going too fast, the doctor must help by advising a slower taper, and if it is going more easily than expected, patient and doctor may agree to go a bit faster, as tolerated. No schedule written in advance survives contact with a real nervous system, which is why this article offers the shape of a taper and not a milligram plan. The plan is written with your prescriber, one reduction at a time.

How do you make doses that small?

Tablets get you part of the way. The larger strengths of mirtazapine tablets are scored for splitting, and generic tablets also come in a smaller, unscored strength, so the first stretch of most tapers uses ordinary pharmacy tablets and a pill cutter. Sooner or later, though, the next proportional cut is smaller than any piece of tablet you can reliably make.

This is where a compounded liquid earns its place. A compounding pharmacy can prepare mirtazapine as a liquid of known concentration, which allows reductions of fractions of a milligram, measured with an oral syringe. Which pharmacy is a question for the visit with your doctor, not for the internet.

One caution belongs here. Switching between manufacturers, or between tablets and liquid, can change how much drug the body absorbs, and a sensitized nervous system notices small differences. Keep the same source when you can, and tell your doctor right away if the pharmacy changes it for you.

Is it withdrawal, or is the depression coming back?

This is the fear underneath most mirtazapine tapers, and it deserves a straight answer. Withdrawal and returning depression can look alike, and even an experienced doctor cannot always tell them apart in a single visit. Timing is the best clue.

Withdrawal tends to arrive within days of a reduction and tends to ease when the dose is held or restored. Depression that is truly returning builds over weeks, does not track the calendar of your cuts, and looks like the illness you remember rather than a new collection of physical sensations. Dizziness, nausea, electric shocks in the head, and vivid dreams are not depression, and this guide to surviving antidepressant withdrawal covers what those symptoms feel like and how patients get through them.

You may be wary of any doctor’s reassurance here, and that wariness is understandable. The drug was prescribed with the promise that it was easy to take, and nobody mentioned that it might be hard to leave. The answer is not to argue about which one it is in the middle of a bad week. Hold the dose, let the week pass, and decide together with clearer eyes.

How long does tapering off of mirtazapine take?

Longer than a fifteen-minute visit would suggest. For a patient who has taken mirtazapine for years, a taper measured in months is reasonable, and a taper measured in weeks is usually a taper measured in symptoms. Some patients need considerably longer, and the calendar has no vote.

Sleep is the part patients worry about most, and with reason. Mirtazapine was often the thing that got them to sleep in the first place, and its sedating effect fades as the dose comes down. Patients often describe a few rough nights after each cut that settle during the hold, and the sleep that returns without the drug tends to be sleep they trust.

There is a larger point here about informed consent. The exit plan should have been part of the conversation on the day the prescription was written, along with the risk of dependence, the alternatives, including no medication at all, and your right to say no. It probably was not. It does not have to stay that way.

How Dr. Leeds approaches a mirtazapine taper.

Dr. Leeds runs a concierge telemedicine practice, not an insurance practice, and it exists for tapers like this one. Patients meet with him weekly by video, often for up to an hour, and reach him by text between visits when a question cannot wait. Every reduction is decided in conversation, with the patient’s reported symptoms as the guide and a hold as the default whenever the nervous system asks for one.

The practice does not prescribe antidepressants as treatment. It helps patients come off of them, at a pace the patient sets, working with compounding pharmacies when tablets can no longer be cut small enough. Care is available to patients throughout Florida by telemedicine, with in-office visits in Fort Lauderdale. If you are ready to plan a slow, patient-directed taper off of mirtazapine, contact Dr. Leeds today.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Dr. Mark Leeds

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist providing concierge telemedicine care in Florida, focused on helping patients safely taper benzodiazepines and other psychiatric medications. A member of the medical advisory board of the Benzodiazepine Information Coalition (BIC) and host of The Rehab Podcast on the Mental Health News Radio Network, Dr. Leeds offers individualized, patient-directed care through weekly one-on-one video appointments. His practice prioritizes dignity, respect, and collaboration, treating each patient as a partner in building a treatment plan tailored to their unique needs and goals.